Article Text

Download PDFPDF

CASE REPORT
Supportive mistletoe therapy in a patient with metastasised neuroblastoma
  1. Jens Kaestner1,
  2. Dietrich Schlodder2,
  3. Christfried Preussler3 and
  4. Bernd Gruhn1
  1. 1 Klinik für Kinder- und Jugendmedizin, Friedrich-Schiller-Universität Jena, Jena, Germany
  2. 2 Research and Development, Helixor Heilmittel GmbH, Rosenfeld, Germany
  3. 3 Medical Science, Helixor Heilmittel GmbH, Rosenfeld, Germany
  1. Correspondence to Dr Christfried Preussler, cpreussler{at}helixor.de

Abstract

Therapies of complementary and alternative medicine (CAM) are used increasingly in paediatric oncology. We present and discuss the influence of supportive mistletoe therapy on factors, such as quality of life, physical ability and performance, and course of disease based on the case of a female patient diagnosed at age 18 with metastasised neuroblastoma, which responded insufficiently to chemotherapy.

  • complementary medicine
  • cancer intervention
  • paediatric oncology

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors BG guided the patient’s therapy. Both BG and JK were attending physicians, provided the medical data and supported the production of the manuscript. DS supplemented and reviewed the manuscript. CP guided and managed the development of the manuscript. Each author approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.